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Abstract
The global HIV response has entered a new phase with the recommendation of treating all persons living with HIV with antiretroviral
therapy, and with the goals of reducing new infections and AIDS-related deaths to fewer than 500,000 by 2020. This new phase
has intensive data requirements that will need to utilize routine data collected through service delivery platforms to monitor
progress toward these goals. With a focus on sub-Saharan African, we present the following priorities to improve the demand,
supply, and use of routine HIV data: (1) strengthening patient-level HIV data systems that support continuity of clinical care and
document sentinel events; (2) leveraging data from HIV testing programs; (3) using targeting data collection in communities and
among clients; and (4) building capacity and promoting a culture of HIV data quality assessment and use. When fully leveraged,
routine data can efficiently provide timely information at a local level to inform action, as well as provide information at scale
with wide geographic coverage to strengthen estimation efforts.
(JMIR Public Health Surveill 2018;4(2):e36)  doi: 10.2196/publichealth.9344
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Background
The global HIV response has entered a new phase with the
recommendation of treating all persons living with HIV with
antiretroviral therapy [1], and with the goals of reducing the
number of new HIV infections and AIDS-related deaths to fewer
than 500,000 by 2020 [2]. This new phase has intensive data
requirements to monitor progress toward these goals.
The infrastructure of national-level public health surveillance
platforms across the most heavily impacted countries,
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particularly in sub-Saharan Africa, is improving. This presents
an opportunity for a major shift in the type of data used to inform
country-level HIV prevention, treatment, and care responses.
Central to this shift are recommendations by the World Health
Organization (WHO) for investing in strategies to collect and
leverage routine HIV data to track the HIV epidemic and
ultimately, the response [3]. Moreover, new laboratory
technologies, the growth of networked information systems,
and the development of sophisticated data collection and
analysis methods offer the potential to develop better strategic
information.
Concurrent with these advances are shifts away from the
mainstays of HIV. It has been suggested that the ethical
underpinnings of unlinked anonymous HIV testing of pregnant
women in sentinel surveillance have weakened, particularly in
areas where HIV status information may be extracted from
routine medical records [4-6]. National household-level surveys
require large investments and provide only periodic data on
which to anchor trend estimates. There remains a widespread
absence of HIV incidence data at a time when the interpretation
of prevalence trends is becoming ever more complex as
treatment continues to expand and survival continues to
lengthen. Intensive community-based cohort studies provide
critical insights on epidemic dynamics but only over a limited
geographic scope [7]. Sentinel HIV treatment cohorts and
clinical databases are compromised by challenges in ascertaining
outcomes and ensuring follow-up [8].
To promote sustainability, operational and surveillance platforms
that utilize the latest computer technology for data storage are
required. These platforms will ideally provide information in a
timely fashion and at a scale and degree of detail that will
improve our understanding of the distributions of HIV risk and
determinants of that risk across settings. Similarly, we need
surveillance systems that can monitor progress towards reducing
the undiagnosed fraction of persons living with HIV, accelerate
their pathway to care, and support retention in care. A greater
focus on strengthening the demand, supply, analysis, and use
of routine HIV data is essential to meet these needs and guide
prevention, testing, and treatment efforts.
Focusing on sub-Saharan Africa, we present the following
priorities for action to improve routine HIV data: (1)
strengthening individualized HIV data systems that support
continuity of clinical care and document sentinel events; (2)
leveraging data from HIV testing programs; (3) promoting
targeted routine data collection in communities and among
clients; and (4) building capacity and promoting a culture of
HIV data quality assessment and use (Multimedia Appendix
1). We define routine data as data generated, through regular
procedure, from service-delivery platforms for prevention,
testing and treatment, community and client surveys designed
to inform to inform programmatic or strategic needs, and
national registries. These data may be paper-based or electronic
(preferably electronic) and presented aggregately or individually
(preferably individually). All of the surveillance data
recommended in this paper can and should be collected
routinely.
Priorities for Action
Strengthen Individualized HIV Data Systems
Although the HIV care continuum [9-12] and 90-90-90 fast-track
strategy [13] have given energy to measuring progress and
driving scale-up in treatment programs, there remains much to
do to ensure progress is accurately tracked. In many sub-Saharan
African countries, patient monitoring data come from multiple
sources, are of varying quality, and are often recorded
electronically long after they have been combined to create
aggregate reports. As these systems frequently monitor a
person’s care pathway only from commencement of treatment,
the pathway from HIV infection to diagnosis and to treatment
is poorly understood, as is the wider clinical experience. Most
current district health information systems rely on aggregate
data making it difficult to assess how complete or accurate the
data are or whether duplicate records are present [14].
Track Patients Within and Across Programs
Central to maximizing the utility of routine data is the idea of
patient tracking. Data systems that track individuals over time
and space are the only practicable way to ensure good clinical
care and program responses. The ability to link individuals in
this way enables the identification of persons lost to follow-up
from one facility who have silently transferred to another
facility, or who have died in the community, thereby informing
targeted patient tracing or back-to-care programs [15]. These
same systems also offer invaluable opportunities for strategic
information based on de-duplicated individual-level records to
compliment traditional reporting through management
information systems in which the data are aggregated at source,
and improve national and global estimates.
Individual patient data leveraged from multiple systems can
provide an important data source for developing a
comprehensive strategic HIV information system, such as case
surveillance [3,14]. To expand existing HIV surveillance
activities, the WHO has recommended adopting or strengthening
such systems [3]. When collated through a comprehensive
strategic HIV information system these patient data can provide
a count of HIV infected and diagnosed individuals across a
specified geographic area, and provide a comprehensive and
timely picture of the care cascade. A comprehensive strategic
HIV information system is but one component among a suite
of components to strengthen the use of patient data in
surveillance. Wherever possible, extracting data from systems
already in place for operational and clinical purposes is preferred
to requiring clinicians to additionally report events for
surveillance purposes.
Develop Unique Universal Personal Identifiers
To facilitate system linkage, better methods are required for the
development and integration of unique, universal, health
identifiers that work across multiple health services and systems,
such as linkage to vital registration, tuberculosis and viral
hepatitis control programs, and maternal, new-born, and child
health systems [3,8,16,17]. Lessons learned from countries with
substantial experience with unique identifiers should be
considered to inform adoption or expansion in other countries.
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Approaches may include civil identification numbers, national
health identifiers or master patient indexes (a database used by
multiple locations to consistently maintain information on each
registered patient ), or developing bespoke matching algorithms
to link records based on existing patient identifying information
(eg, sex, age, and a representation of name such as a Soundex)
[18]. In developing unique identifiers, it is essential to consult
with and address the concerns of clients and civil society on the
potential for confidentiality breaches and consequent human
rights abuses.
Utilize Data From HIV Testing Platforms
The growing array of mechanisms for delivering HIV testing
in clinical and non-clinical settings offers great potential for
epidemiological intelligence. However, realizing this potential
requires careful thought and investment.
Re-Focus on Data Systems for New Diagnoses
Data collected through HIV testing platforms, both negative
and positive results, can inform prevention and clinical service
provision. Site-specific information on newly diagnosed persons,
including sex, age (as derived from date of birth), CD4 cell
count and, where feasible, probable route of infection and a
marker of residence, can be used to identify geographical regions
and groups where HIV incidence is elevated. Spatial maps can
be produced from these data to inform the provision of targeted
and to-scale prevention and treatment services. Information on
persons testing HIV negative can be utilized to inform
appropriate prevention service provision. Developing data
quality assurance protocols can help ensure the HIV testing data
we collect are comprehensive and robust.
Testing data are critical for monitoring early (CD4 cell count
greater than 350 cells/µL) and, conversely, late diagnosis (less
than 350 cells/µL). As low CD4 cell counts can be triggers for
more intensive follow-up [19], testing data can be used to
monitor differentiated care models and promote earlier
diagnosis. Testing data are also critical for monitoring the
pathway from diagnosis to care, an important and often ignored
step in the care cascade. In addition, to objectively monitor
performance across the 90-90-90 targets, a first stage
denominator of overall HIV prevalence is required. To monitor
the first and second 90s we require an estimate of persons living
with HIV who have been diagnosed for the numerator and
denominator, respectively. If systems are strengthened, routine
testing data should in the future directly provide estimates of
diagnosed HIV, and indirectly through modeling, of undiagnosed
HIV in sub-Saharan African settings.
Incorporate Data from Multiple Testing Platforms
Data collected through facility, community, and home-based
testing platforms, key population outreach programs and,
increasingly, through the expansion of self-testing all offer the
potential for informing action. To utilize these data, a better
understanding of the impact of shifting combinations, and
increased coverage, of testing provision on reducing the number
of previously untested persons and the number undiagnosed is
needed, as is gaining a better understanding of the drivers for
testing outside of traditional clinical settings.
The ongoing shift for surveillance purposes from unlinked
anonymous testing in antenatal sentinel sites to using routine
antenatal testing data collected through existing HIV program
monitoring systems provides an opportunity to improve the
level of detail by which HIV prevalence estimates are presented
[20,21]. If coverage of HIV testing services at antenatal clinics
is high, and if the available data are of high quality, this shift
can improve the representativeness of HIV prevalence estimates
as they are among all pregnant women rather than just among
women from a non-representative sample of health facilities.
However, there is a need to conduct quality assurance
assessments of these data as there are remaining concerns that
routine data, as compared to sentinel site data, may present
greater variation in coverage and quality [22-24].
The expanding number of mechanisms for routinely delivering
HIV tests ensures methodological improvements are required
to appropriately analyze and interpret the data generated at the
local and national level. It is likely that, amongst others,
care-seeking patterns, existing knowledge of HIV status, test-kit
quality, missing patient responses, and a variable prevalence of
electronic data systems and standardized practices will influence
estimates.
Employ Recency Assays
Understanding where and among whom new infections are
occurring is critical to plan programs and to track the incidence
of new infections over time to assess whether control measures
are working. To date, most estimates of HIV incidence in
sub-Saharan Africa come from modeling efforts based on trends
in HIV prevalence, births and deaths, and information about
the coverage of treatment programs. In some settings estimates
that do not rely on modeling are based on community cohort
studies with repeat HIV testing, although this has rarely, with
some exceptions [25], been done at national scale.
Recent infection testing algorithms (RITA) can distinguish
recently acquired infection from long-standing infection [26,27].
Recency testing offers the potential to inform action for
individual patients, their networks and programs and, if
incorporated into routine testing and programmatic surveys, to
strengthen estimates of incidence. Examples might include
identifying clusters of infection among key populations in
outreach testing platforms, or complimenting data on HIV
prevalence in routine testing of pregnant women with
information on recency. Attention to test accuracy, data quality,
ethics, sample size, and analysis and interpretation will be
necessary. Nevertheless, the wider adoption of these
technologies within routine data systems, especially if the price
can be reduced, has the potential to bring new strategic
information.
Targeted Routine Data Collection Among Communities
and Clients
Strategically deployed community-based and client surveys (eg,
tracing studies) can routinely be conducted to complement our
understanding gleaned through prevention, testing, and treatment
programs. They can inform and correct some of the biases of
routine programmatic data, and provide information about
individuals and populations at risk of infection or treatment
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failure, the scale and nature of their needs, and potential barriers
to the effectiveness of prevention programs [28]. These surveys
are often cost efficient compared to population-wide surveys
and provide an opportunity to contextualize populations
represented within routinely collected service data, and to
develop HIV prevention cascades to guide prevention programs
[29,30]. Because these populations are often hidden and
stigmatized, and may practice, in some cases, illegal behaviors,
novel methods are required.
Systematize Key Population Surveillance
In sub-Saharan Africa, venue-based and respondent-driven
sampling strategies are commonly used to characterize key
populations for whom there is no practical sampling frame.
Venue-based sampling focuses on settings where key
populations congregate, while respondent-driven sampling
leverages networks of people sharing risk characteristics [31-33].
Although widely used in Africa, these approaches have not to
date received the same level of attention as national-level general
population surveys.
These sampling methods tend to be based in local sites and often
have not been designed to be representative at larger scale.
Current practice has led to a range of funders and programs
deploying a variety of sampling methods. Heterogeneity in
methods and sample populations limit the potential for the data
to be used to track trends or be incorporated in modeling efforts
designed to inform resource allocation decisions.
The implications of which sampling approach is used has been
shown to be significant, with the characteristics of the
populations recruited differing [33]. Through gaining a greater
understanding of the strengths, limitations, and interpretation
of sampling methods, a more systematic approach to their
deployment can be developed. Decision-trees can be adopted
to highlight which assumptions were met, which were not, and
how best to proceed given different circumstances and statistical
tools developed to derive best estimates from data arising from
routine services and targeted surveys.
Identify Populations With Greatest Needs and Develop
Tools to Guide Service Provision
Surveillance for program improvement requires identifying the
location, needs and size of populations at high risk, and
recognizing individuals may move in and out of periods of high
risk and/or fall under one or more high-risk behavioral group.
It is essential that program decision-making is based not only
on those reached by services but also those unreached.
There is a growing call for community-based efforts that
differentiate sub-groups and risk to inform targeted service
provision. Within the Determined, Resilient, Empowered,
AIDS-Free, Mentored, and Safe Women (DREAMS) initiative,
the Girl Roster tool is being deployed to help reach adolescent
girls in need, while variants of network-based referral can also
be used to identify young women who sell or trade sex for
referral into programs; approaches such as peer-led
micro-planning can be deployed to strengthen programming
[34-36].
Build Capacity and Promote a Culture of HIV Data
Quality Assessment and Use
As good local data spur action locally and create better data for
onward reporting, the systems designed ought to be sustainable
and responsive to the local context and produce data that are
user-friendly, sustainable, and meet the needs of stakeholders
at various levels. Long-term investment in human and
technological capacity is required so that people within highly
impacted countries can create their own solutions and develop
sustainable practice. Collectively, we should avoid demanding
more data unless this can be derived without impact on data
collectors or front-line clinicians.
Encourage Responsibility for Data quality at the Local
Level
Data quality at the local-level can be improved through
promoting timely, comprehensive and accurate facility-based
record keeping, matching data needs to setting, and building
buy-in and trust among stakeholders. Engagement with and
training of frontline data staff are critical. Understanding the
needs of clinical staff is also critical. If data systems are
strengthened for clinical care governance, data quality and
strategic information will benefit. Deriving
population-representative strategic data from routine clinical
and/or health systems will also reduce the potential for data
collection for surveillance purposes becoming a separate
resource-intensive activity in itself.
Evaluate Data Quality
At the sub-national and national level, a standardized approach
to system design, reducing redundancy, and limiting the
development of parallel systems (systems with a shared purpose
developed independent of one another) should be encouraged.
Through reviewing existing systems and/or surveillance
frameworks [37,38], elements of transferable practice can be
identified to inform system design and the development of
training materials.
The engagement and training of data stewards at the sub-national
and national-level (eg, district and national Minister of Health
staff) to oversee programmatic, clinical, and surveillance
activities are critical. These custodians can promote robust
feedback loops so that the common problem of data travelling
only in one direction, from facility to health departments in
aggregate form, can be avoided. Feedback to those who collect,
collate, and report data should rank reporting sites according to
data quality and program outcomes. Feedback should
incorporate the use of maps and dashboards, and make clear
what the benefits of using the data provided have been (eg,
informing policy and interventions).
To ensure data outputs are interpreted correctly, assessments
of data sources are required to indicate quality and value. For
example, to compare results across populations and time for
each stage of the care cascade, a traffic light system could be
used to indicate confidence levels in data sources of high,
medium, and low. To generate high quality data, and promote
accurate interpretation, conducting quality assessments and
analyses to investigate and correct some of the biases of routine
data is also needed. Bias may arise, from missing data,
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non-representativeness, double counting (aggregate data
particularly suffer from this), or loss to follow-up. Through
identifying bias, methods such as adjustment factors, to support
the interpretation of routine data outputs, can be designed.
Develop Procedural Documents
At all levels, standard operational procedures for data collection
and quality assurance should be developed, promoted, and
updated regularly. These procedural documents can specify how
routine data quality assessments are to be conducted and instruct
how identified errors are addressed. They can stipulate
standardized analytical methods for producing useful
programmatic, clinical and surveillance outputs that account
for potential biases and include accurate assessments of error,
uncertainty, and explicit consideration of important assumptions.
These documents can also provide guidance for conducting
regular output evaluations to ensure accuracy, to ensure the
needs of users are being met, and to monitor impact.
Consider Timeliness of HIV Data Cycles
Data cycles need to be feasible and designed to meet the
different needs of a variety of stakeholders. For clinical
activities, it is required that data be collected, reviewed, and
shared as close to real time as possible. Such provision of data
can enable missed appointments to be acted upon immediately.
For surveillance activities, data producers will ideally collate
as few variables as necessary, and only those that inform action.
They will also assess the minimum period required for
conducting comprehensive data collection and quality
improvement, and producing and reviewing meaningful outputs.
In conjunction with this, data users should assess the timeframes
within which they can receive, review, and use the data for
program improvement. The development and endorsement of
standard operating procedures can guide these efforts.
Discussion
To reduce HIV incidence and mortality in sub-Saharan Africa
we need to provide effective prevention methods, identify all
individuals living with undiagnosed HIV infection, improve the
pathway between diagnosis and care, retain people once they
are in care, and promote antiretroviral therapy adherence. To
achieve this a new phase must be entered, one where we
innovate and improve the routine data systems that support HIV
prevention and care and where we shift from using routine data
purely for descriptive purposes towards directly informing and
improving clinical care and program performance. Robust data
to inform advocacy, to secure resources, and to create an
environment conducive to better rights and fit within national
monitoring and evaluation policies are required.
Here, we presented four priorities that will result in durable and
replicable data systems that collect, store, and produce
individual-level data, and that give rise to user-friendly tools
that can be used by local, national, and international practitioners
to drive more effective and efficient clinical management and
prevention and care programming. We focus on routine data
that are, or might be, collected in sub-Saharan Africa as part of
service delivery requirements. We are united in our appreciation
of the value of national surveys of HIV prevalence and
incidence, community-based cohort studies, and research studies
and trials, but our focus is now on routine HIV data systems
that will be central to the next wave of HIV strategic
information. While we focused on HIV-specific data, we also
recognize the enormous value of strengthening vital registration
and broader health information systems.
In promoting the use of routine data we need to assess the level
of disaggregation useful to inform action and recognize that
uncertainty and/or imprecision increases with the level of
disaggregation. We also need to collect and present data by
geographies that map to how programs and services are
delivered.
When fully leveraged, routine data can efficiently provide timely
information at a local level to inform action, as well as provide
information at scale with wide geographic coverage to
strengthen estimation efforts. To maximize the use of these data
we need to overcome complex challenges. We need to promote
sustainability through investment in data system design,
implementation and capacity, and to ensure the data we produce
are credible and valuable through strong attention to data quality
and use, and through careful analysis and investigation of
potential biases.
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